Why and How People Decide to Stop Taking Prescribed Psychiatric Medication: Exploring the Subjective Process of Choice

被引:74
作者
Roe, David [1 ]
Goldblatt, Hadass [2 ]
Baloush-Klienman, Vered [1 ]
Swarbrick, Margaret [3 ]
Davidson, Larry [4 ]
机构
[1] Univ Haifa, Fac Social Welfare & Hlth Sci, Dept Community Mental Hlth, IL-31905 Haifa, Israel
[2] Univ Haifa, Fac Social Welfare & Hlth Sci, Dept Nursing, IL-31905 Haifa, Israel
[3] Univ Med & Dent New Jersey, Dept Psychiat Rehabil & Behav Hlth Care, Newark, NJ 07103 USA
[4] Yale Univ, Program Recovery & Community Hlth, New Haven, CT 06520 USA
关键词
serious mental illness; psychiatric medication; adherence; qualitative research; SHARED DECISION-MAKING; ADHERENCE; SCHIZOPHRENIA; ILLNESS; NONADHERENCE; PREDICTORS; PSYCHOSIS; IMPACT;
D O I
10.2975/33.1.2009.38.46
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Despite the piling evidence supporting the effectiveness of psychiatric medication, research has consistently shown that only about half of those administered treatment actually take it as prescribed. The purpose of the present study was to explore why and how people with a serious mental illness (SMI) choose to stop taking prescribed medication. Method: Seven persons with SMI who had been prescribed and had used medication in the past, but had not taken medication for at least a year, participated in semi-structured interviews, which were recorded and later transcribed. Qualitative analysis provided a foundation for sketching a hypothesized five-stage model of the process involved in choosing to stop medication. Results: This study revealed the subjective experience of taking medication, dilemmas it evokes, and the struggle to develop a personal perspective, plan and choice with regard to medication use. Conclusions: Implications of these findings are discussed, emphasizing the importance of the "doctor-patient" relationship context.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 41 条
[1]   Shared decision-making and evidence-based practice [J].
Adams, JR ;
Drake, RE .
COMMUNITY MENTAL HEALTH JOURNAL, 2006, 42 (01) :87-105
[2]   Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care [J].
Aikens, JE ;
Kroenke, K ;
Swindle, RW ;
Eckert, GJ .
GENERAL HOSPITAL PSYCHIATRY, 2005, 27 (04) :229-236
[3]   SUBJECTIVE RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA [J].
AWAD, AG .
SCHIZOPHRENIA BULLETIN, 1993, 19 (03) :609-618
[4]  
BALOUSHKLEINMAN V, 2007, THESIS TEL AVIV U TE
[5]   THE CONTENT AND CONTEXT OF COMPLIANCE [J].
BEBBINGTON, PE .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 9 :41-50
[6]  
Bollini P, 2004, J Psychiatr Ment Health Nurs, V11, P668, DOI 10.1111/j.1365-2850.2004.00780.x
[7]   A 2-YEAR PROSPECTIVE-STUDY OF TREATMENT COMPLIANCE IN PATIENTS WITH SCHIZOPHRENIA [J].
BUCHANAN, A .
PSYCHOLOGICAL MEDICINE, 1992, 22 (03) :787-797
[8]   Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment [J].
Bultman, DC ;
Svarstad, BL .
PATIENT EDUCATION AND COUNSELING, 2000, 40 (02) :173-185
[9]   Medication adherence of individuals with a first episode of psychosis [J].
Coldham, EL ;
Addington, J ;
Addington, D .
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 106 (04) :286-290
[10]   Shared decision making and medication management in the recovery process [J].
Deegan, Patricia E. ;
Drake, Robert E. .
PSYCHIATRIC SERVICES, 2006, 57 (11) :1636-1639